Veterinary Research Communications· 2026Q1
Sarcocystis sp. infection associated to encephalomyelitis and myositis in a Brazilian dog
- 0citations
- Q1SCImago
- 2026year
Short summary
A fatal case of meningoencephalomyelitis and myositis caused by Sarcocystis sp. is reported in a dog in Brazil, marked by acute tetraparesis, blindness, and protozoal schizonts in affected tissues.
AI-generated from the title and abstract; the full text is not read.
Key points
- First report of severe clinical canine sarcocystosis in South America.
- Dog presented with acute non-ambulatory tetraparesis, generalized muscle atrophy, and blindness.
- Histopathology revealed severe, multifocal necrotizing meningoencephalomyelitis and myositis.
- Immunohistochemistry confirmed Sarcocystis sp. and excluded Toxoplasma gondii and Neospora caninum.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract Sarcocystis sp.-induced disease is known especially in horses, in which S. neurona is the primary causative agent of Equine Protozoal Myeloencephalitis in the Americas. While horses are aberrant hosts, the range of susceptible species includes marine mammals, raccoons, and cats. Reports of clinical disease in dogs are rare, remaining unreported in South America. This study describes the clinical, pathological, and immunohistochemical findings of a naturally occurring, fatal case of meningoencephalomyelitis and myositis caused by Sarcocystis sp. in a dog in Brazil. A 5-year-old mixed-breed bitch presented with acute non-ambulatory tetraparesis, generalized muscle atrophy, and blindness. Despite supportive therapy, the patient deteriorated and was euthanized. Gross findings included enlarged lymph nodes, moderate splenomegaly and hepatomegaly, with multifocal mild fibrin deposition on the liver capsule, accompanied by multifocal mild hemorrhages in the pancreas. Histopathology demonstrated severe, multifocal necrotizing meningoencephalomyelitis, myositis, splenitis, lymphadenitis and interstitial pneumonia, associated with intralesional protozoal schizonts. Immunohistochemistry supported immunolabelling consistent with Sarcocystis sp. while excluding Toxoplasma gondii and Neospora caninum . To the authors’ knowledge, this represents the first report of clinical canine sarcocystosis with this severity in South America supported by histopathological and immunohistochemical findings. These findings support that Sarcocystis sp. should be considered a differential diagnosis for canine progressive neurological disease, highlighting the potential role of wildlife reservoirs in the disease’s epidemiology.
The authors' abstract, as published at the source. Veterinary Research Communications, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
ParasitologyImmunology and Microbiology